DE3445253C2 - - Google Patents

Info

Publication number
DE3445253C2
DE3445253C2 DE3445253A DE3445253A DE3445253C2 DE 3445253 C2 DE3445253 C2 DE 3445253C2 DE 3445253 A DE3445253 A DE 3445253A DE 3445253 A DE3445253 A DE 3445253A DE 3445253 C2 DE3445253 C2 DE 3445253C2
Authority
DE
Germany
Prior art keywords
cysteine
mmol
serum
acid
hcl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3445253A
Other languages
German (de)
English (en)
Other versions
DE3445253A1 (de
Inventor
Des Erfinders Beantragt Teilnichtnennung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Madaus Holding GmbH
Original Assignee
Madaus AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus AG filed Critical Madaus AG
Priority to DE3445253A priority Critical patent/DE3445253A1/de
Priority to CA000496481A priority patent/CA1263603A/en
Priority to CH5270/85A priority patent/CH665773A5/de
Priority to US06/808,014 priority patent/US4849452A/en
Priority to JP60278106A priority patent/JPS61140522A/ja
Publication of DE3445253A1 publication Critical patent/DE3445253A1/de
Application granted granted Critical
Publication of DE3445253C2 publication Critical patent/DE3445253C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3445253A 1984-12-12 1984-12-12 Nephrologisch-urologisches arzneimittel Granted DE3445253A1 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE3445253A DE3445253A1 (de) 1984-12-12 1984-12-12 Nephrologisch-urologisches arzneimittel
CA000496481A CA1263603A (en) 1984-12-12 1985-11-28 Nephrological-urological medicine
CH5270/85A CH665773A5 (de) 1984-12-12 1985-12-09 Nephrologisch-urologisches arzneimittel.
US06/808,014 US4849452A (en) 1984-12-12 1985-12-11 Nephro-urological medicament
JP60278106A JPS61140522A (ja) 1984-12-12 1985-12-12 腎ぞう病‐泌尿器科用医薬

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3445253A DE3445253A1 (de) 1984-12-12 1984-12-12 Nephrologisch-urologisches arzneimittel

Publications (2)

Publication Number Publication Date
DE3445253A1 DE3445253A1 (de) 1986-06-26
DE3445253C2 true DE3445253C2 (enExample) 1991-09-26

Family

ID=6252540

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3445253A Granted DE3445253A1 (de) 1984-12-12 1984-12-12 Nephrologisch-urologisches arzneimittel

Country Status (5)

Country Link
US (1) US4849452A (enExample)
JP (1) JPS61140522A (enExample)
CA (1) CA1263603A (enExample)
CH (1) CH665773A5 (enExample)
DE (1) DE3445253A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445253A1 (de) * 1984-12-12 1986-06-26 Dr. Madaus & Co, 5000 Köln Nephrologisch-urologisches arzneimittel
GB2245491A (en) * 1990-06-25 1992-01-08 Medvet Science Pty Ltd Inhibition of metabolic oxalate formation
US6764693B1 (en) 1992-12-11 2004-07-20 Amaox, Ltd. Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants
ITMI20032528A1 (it) * 2003-12-19 2005-06-20 Francesco Santangelo Uso di cistina o di cisteina per la prevenzione e il
US8148356B2 (en) 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
ES2486441B1 (es) * 2014-04-02 2015-06-11 Universitat De Les Illes Balears Preparaciones combinadas de acidificantes urinarios e inhibidores de la cristalización y su aplicación para el tratamiento o prevención de la litiasis renal fosfática o inducida por fosfato cálcico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378351A (en) * 1980-07-11 1983-03-29 Vojislav Petrovich Methods of treating bacterial, viral or parasitic diseases
IT1195288B (it) * 1981-11-05 1988-10-12 Zambeletti Spa L Composizione farmaceutica per la terapia di calcolosi renale infetta
FR2521429B1 (fr) * 1982-02-15 1988-10-28 Mayoly Spindler Laboratoires Nouvelles compositions a effet antiasthenique puissant a base de sels doubles de l'acide ascorbique et d'un diacide amine
US4721705A (en) * 1983-09-26 1988-01-26 Chemish Adviesbureau Drs. J.C.P. Schreuder B.V. Skin treatment compositions
DE3445253A1 (de) * 1984-12-12 1986-06-26 Dr. Madaus & Co, 5000 Köln Nephrologisch-urologisches arzneimittel

Also Published As

Publication number Publication date
DE3445253A1 (de) 1986-06-26
CH665773A5 (de) 1988-06-15
US4849452A (en) 1989-07-18
CA1263603A (en) 1989-12-05
JPS61140522A (ja) 1986-06-27
JPH0149328B2 (enExample) 1989-10-24

Similar Documents

Publication Publication Date Title
DE69530412T2 (de) Zusammensetzung aus cisplatin in kombination mit 2,2'-dithio-bis(ethansulfonat)(dimesna)
DE69629184T2 (de) Verwendung von vitamin d2 oder vitamin d4-derivaten zur herstellung eines medikamentes zur behandlung des sekundären hyperparathyroidismus
DE69000645T2 (de) Bei kuehlschranktemperatur stabile waessrige folinatloesung sowie verfahren zu deren herstellung.
DE3789576T2 (de) Verwendung von Inositol-Triphosphat zur Behandlung von Metallvergiftung.
DE2712786C2 (enExample)
DE69103029T2 (de) Intravenöse Lösungen zur Beeinflussung der Nierenfunktion und zur Instandhaltungstherapie.
EP1465641B1 (de) Arzneimittel enthaltend deuterium zur behandlung der zuckerkrankheit
DE68914922T2 (de) Verwendung von Inositoltrisphosphat zur Herstellung eines Arzneimittels gegen Knochenerkrakungen.
DE3875867T2 (de) Kalziumzusaetze.
DE3880587T2 (de) Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.
DE2329158A1 (de) Heilmittel zur behandlung der ketonaemie und der osteomalazie bei vieh, insbesondere hornvieh
EP0398165B1 (de) Kombinationspräparate enthaltend Rifampicin und Thioacetazon sowie gegebenenfalls Isonicotinsäurehydrazid oder Ethambutol als aktive Wirkstoffe
EP0024023B1 (de) Antimykotische Mittel mit höherer Freisetzung der Wirkstoffe
EP0245669B1 (de) Pharmazeutisches Präparat zur Verhütung der Schädigung lebender Zellen durch freie Radikale, beziehungsweise zur Erhöhung der Wirksamkeit von organischen Schwefelverbindungen und Verfahren zur Erhöhung der Lebensdauer isolierter Organe
DE68919673T2 (de) Verfahren zur behandlung und vorbeugung des verlustes von knochenmasse.
CH665773A5 (de) Nephrologisch-urologisches arzneimittel.
DE69023939T2 (de) Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten.
DE3809625C2 (enExample)
DE19828068C2 (de) Mittel zur spezifischen Hemmung osteoklastärer Knochenresorption
DE3628010A1 (de) Arzneimittel fuer die verwendung bei der behandlung von hypertonie
EP0673913B1 (de) Calcium-Alkalicitratverbindungen und deren Verwendung als Arzneimittel
CH648208A5 (de) Pharmazeutisches mittel zur herabsetzung der endogenen oxalatbildung.
DE2011499A1 (de) Arzneimittel aus Germaniumsäure und Cystein und Verfahren zu seiner Herstellung
AT234277B (de) Verfahren zur Herstellung oral verabreichbarer Eisenpräparate
DE3901508C2 (de) Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: MADAUS AG, 5000 KOELN, DE

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee